Recent News

Screening for Mesothelioma: Detecting Mesothelioma Before Symptoms

December 26, 2017

Diagnosing mesothelioma in the early stages has proven to be difficult. Biomarkers and diagnostic procedures are the most common way of determining this cancer’s existence, but if mesothelioma could be[…]

Read More

Risk Factors From Intraperitoneal Chemotherapy Could Be Determined By Early Biomarker

December 19, 2017

Peritoneal mesothelioma is an extremely rare form of mesothelioma that affects the abdominal lining, or peritoneum.  Caused by asbestos exposure, peritoneal mesothelioma can be difficult to diagnose because symptoms are[…]

Read More

ONCOS-102 Passes Safety Evaluation in Phase I Clinical Trials, Phase II Clinical Trial Recommended

December 12, 2017

A new immunotherapy developed by Targovax has recently passed Phase I clinical trials and is set to begin Phase II evaluation of this new treatment that may help those suffering[…]

Read More

Legitimate Data and Research is Required for Treatment Approval

December 7, 2017

For cancer patients who have little success with traditional chemotherapy and radiation treatments, immunotherapy treatments are becoming known alternatives – working with the body’s own immune system to become stronger[…]

Read More

Pleural Catheter vs. Pleurodesis

December 1, 2017

Symptoms for pleural mesothelioma are typically centered on lung function breathing, with shortness of breath (dyspnea), pleural effusion (fluid build-up), and pain in the chest being the primary indicators.  There[…]

Read More

Funding Needed for Lung Cancer Awareness and Research – How You Can Help

November 29, 2017

As November draws to a close, so does Lung Cancer Awareness Month, but that doesn’t mean we should forget about this devastating cancer that affects hundreds of thousands of people[…]

Read More

Smoking Plus Asbestos Exposure – A Deadly Combination

November 21, 2017

In 2004, the American Thoracic Society called asbestos “the largest cause of occupational cancer in the United States and a significant cause of disease and disability from nonmalignant disease.” Asbestos[…]

Read More

Autophagy Inhibitors Potentially Make Chemotherapy More Effective in Mesothelioma Patients

November 15, 2017

Autophagy is a natural and regulated self-degradative process in cells that plays a critical role in balancing sources of energy and removing aggravated proteins, damaged organelles, and pathogens. During autophagy,[…]

Read More

Bevacizumab – A Positive Treatment with Serious Side Effects

November 7, 2017

Bevacizumab (Avastin) is commonly viewed as chemotherapy treatment because when administered intravenously, it is particularly effective in controlling such illnesses such as lung cancer and colon cancer. However, it is[…]

Read More

November is Lung Cancer Awareness Month

November 2, 2017

The National Cancer Institute places lung cancer as the leading cause of death from cancer in the United States. One out of every four cancer deaths is attributable to lung[…]

Read More